Overview

A Study of Staccato Loxapine (ADASUVE®) for Inhalation

Status:
Unknown status
Trial end date:
2020-08-01
Target enrollment:
Participant gender:
Summary
Phase 3 safety and efficacy study of Staccato Loxapine in the treatment of acute agitation in schizophrenic or bipolar disorder patients.
Phase:
Phase 3
Details
Lead Sponsor:
Lee's Pharmaceutical Limited
Treatments:
Loxapine